Some ligands involved in T1D progression, such as lymphotoxin (LTα1β2), CD40L and the TNF superfamily 14 (TNFSF14, also named LIGHT) can activate the non-canonical NF-κB pathway [5, 8, 10, 11]. The gene discussed is NFKB1; the disease is type 1 diabetes mellitus.